Vigil Neuro
0 followers
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscienc... Read more
Org chart
Ivana Magovčević-Liebisch
President & CEO
Ivana Magovčević-Liebisch
Collapse
David Gray
Chief Science Officer
Andreas Meier
SVP, Clinical & Medical Sciences
Evan Thackaberry
SVP & Head, Early Development
Weeteck Yeo
SVP, Strategic Operations
Jessica Stromme
SVP, Program Leadership & Portfolio Management
Berkley Lynch
VP, Biology
Jonathan Houze
VP, Small Molecule Discovery
Samantha Zappia
VP, Regulatory Affairs & Quality
Christian Mirescu
VP & Head, Neuroimmunology
Cynthia Cassandro
VP, Patient Advocacy & Engagement
Kevin Durfee
VP & Head, Information Technology
Elizabeth Thompson
Senior Director, Biometrics
Liyue Huang
Senior Director, Drug Metabolism & Pharmacokinetics
Dwayne Stanley
Senior Director, Program Management
Evangelia Hatzis
Senior Director, Program Management
Craig Bodycombe
Director, Analytical Development
Sharon Morani
Senior Director, Facilities & Operations
Borislav Dejanovic
Director, Translational Sciences
Yael Mandelblat-Cerf
Associate Director, Translational Sciences
Anadina Garcia
Senior Manager, Nonclinical Operations
Meghan Pagliarini
Executive Liaison to the President & CEO
Heidi Mizenko
Senior Human Resources Associate
Jane Lydon
Executive Assistant
Shannon Ryan
Clinical Project Manager
Julia Keefe
Associate Director, Investor Relations & Corporate Communications
Jordan Jara
Clinical Trial Manager
Donald McLaren
Director, Clinical Biomarkers & Translational Medicine
Clarissa Martinez-Rubio
Associate Director, Patient Advocacy
Leah Gibson
VP, Investor Relations & Corporate Communications
Michael Cohen
Associate General Counsel
Alysia Martins
Principal Research Associate, Discovery Biology
Rizwan Manzer
Director, CMC & Technical Operations
